scispace - formally typeset
G

Ganesh Devidas Mahale

Researcher at Savitribai Phule Pune University

Publications -  8
Citations -  50

Ganesh Devidas Mahale is an academic researcher from Savitribai Phule Pune University. The author has contributed to research in topics: Dibenzothiazepine & Ether. The author has an hindex of 4, co-authored 8 publications receiving 48 citations. Previous affiliations of Ganesh Devidas Mahale include Ipca Laboratories Ltd..

Papers
More filters
Journal ArticleDOI

Efficient Method for Demethylation of Aryl Methyl Ether Using Aliquat-336

TL;DR: In this paper, a rapid method for selective cleavage of aryl methylethers can be achieved in the presence of a protic acid and a catalytic amount of phase transfer catalyst (Aliquat-336).

Synthesis and antibacterial activities of new dibenzothiazepine derivatives

TL;DR: In this paper, the synthesis of new derivatives possessing antibacterial activity has attracted considerable attention owing to the continue increase in bacterial resistance and the need for compounds which exhibit antidopaminergic activity and pharmaceutical activity to overcome such undesired side effect.
Journal ArticleDOI

Synthesis and Antibacterial Activities of New Dibenzothiazepine Derivatives.

TL;DR: In this paper, the newly synthesized dibenzothiazepines (III) were evaluated for their activity against both Gram-positive and Gram-negative bacteria, and the results showed that they were effective against both gram positive and gram negative bacteria.
Journal ArticleDOI

A green process for the preparation of 11-{4-[2-(2-hydroxyethoxy) ethyl]-1-piperazinyl}dibenzo[b,f][1,4]thiazepine

TL;DR: In this article, a green process for the synthesis of 11-{4]-2-(2-hydroxyethoxy)ethyl]- 1-piperazinyl}dibenzo[b,f][1,4]thiazepine by the reaction of 11-(1-pariazinyl) dibenzyncyclohexane or its dihydrochloride salt with 2-chloroethoxy ethanol in the presence of an inorganic base and water is reported (conversion 99.9 % in a short time and without any impurities).
Patent

Manufacturing process for methyl phenidate and intermediates thereof

TL;DR: In this article, the selective and complete reduction of pyridine ring in a biaryl system comprising ∝-substituted or non-subtituted benzene ring and relates more specifically for the manufacture of methylphenidate, which is used for treatment of Attention Deficit Hyperactive Disorder (ADHD) and also acts as central nervous system stimulant, by using palladium/C in a solvent such as C1-C4 alcohols in presence of molar quantities of organic and/or inorganic acids.